Boston Scientific Shares Fall After Citigroup Downgrade

MT newswire2026/09/17 18:32

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

02:32 PM EDT, 09/17/2026 (MT Newswires) -- Boston Scientific (BSX) shares were down over 1% in Thursday trading after Citigroup downgraded the stock to neutral from buy, and cut its price target to $50 from $57. Trading volume stood at more than 16.1 million shares, compared with a daily average of about 20.4 million. Price: 43.35, Change: -0.56, Percent Change: -1.29

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

AppLovin (APP.US) released its financial results for the third quarter of 2026 (ending September 30) after the US stock market closed on Wednesday. The advertising technology company once again delivered a "textbook-level" performance: revenue, net profit, and adjusted EBITDA all reached record highs for a single quarter, with profitability indicators far ahead of major advertising platforms.

智通财经•2026/11/04 22:32

BUZZ - Edwards Lifesciences shares rise after raising 2026 profit outlook

路透社•2026/11/04 22:32

Updated: Coty exceeds expectations as luxury brand business boosts performance during business transformation

路透社•2026/11/04 22:19

BUZZ-AppLovin shares surge due to profit growth in the third quarter

路透社•2026/11/04 22:19